Rule 144 filing shows CRWV insider and trust share sales via 10b5-1

Rhea-AI Filing Summary

A Form 144 notice reports a planned sale of 1,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate market value of 101230.00. The issuer has 386,401,201 common shares outstanding, and the shares to be sold were acquired as founders shares on 02/25/2019 from the issuer.

The filing also lists prior sales over the past three months by various related sellers, primarily under Rule 10b5-1 trading plans. These include multiple common stock sales on dates in December 2025 and January 2026 by several trusts and entities at the same Livingston, NJ address, as well as a Non-Affiliate Donee sale of 257,733 shares on 12/01/2025 for gross proceeds of 19592527.61.

Insights

Insider trading and disclosure analyst

Form 144 shows a modest new planned sale alongside larger recent 10b5-1 sales.

The notice covers a planned sale of 1,000 common shares with an aggregate market value of 101230.00, against 386,401,201 shares outstanding. The seller acquired these as founders shares on 02/25/2019, which indicates long-held stock being sold rather than a recent grant. The transaction will be executed through Morgan Stanley Smith Barney’s Executive Financial Services unit.

The disclosure of past three-month activity highlights a pattern of Rule 10b5-1 plan sales by multiple related trusts and entities at the same address, plus a Non-Affiliate Donee selling 257,733 shares for 19592527.61 on 12/01/2025. Because these are pre-arranged 10b5-1 trades and the filing does not provide the holders’ total ownership, the investment significance is hard to gauge from this data alone. Overall, this appears as routine liquidity activity rather than a clearly thesis-changing event.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1000	101230.00	386401201	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/25/2019	Founders Shares	Issuer			1000	02/25/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CANIS MAJOR SM TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/12/2026	500	44309.80
10b5-1 Sales for Brannin J. McBee 2022 Irrevocable Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/12/2026	25000	2219467.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/12/2026	102835	9129557.61
10b5-1 Sales for CANIS MAJOR 2024 IRREVOCABLE TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/12/2026	3000	265858.80
10b5-1 Sales for CANIS MAJOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/12/2026	1000	88619.60
10b5-1 Sales for CANIS MINOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/12/2026	1000	88619.60
10b5-1 Sales for CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/12/2026	25000	2219467.50
10b5-1 Sales for CANIS MINOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/12/2026	8335	739970.46
10b5-1 Sales for CANIS MAJOR SM TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/05/2026	500	39638.95
10b5-1 Sales for Brannin J. McBee 2022 Irrevocable Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/05/2026	25000	1982062.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/05/2026	102835	8153015.89
10b5-1 Sales for CANIS MAJOR 2024 IRREVOCABLE TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/05/2026	3000	237833.70
10b5-1 Sales for CANIS MAJOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/05/2026	1000	79277.90
10b5-1 Sales for CANIS MINOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/05/2026	1000	79277.90
10b5-1 Sales for CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/05/2026	25000	1982062.50
10b5-1 Sales for CANIS MINOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/05/2026	8335	660819.64
BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	57636	4182723.27
10b5-1 Sales for CANIS MAJOR SM TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/29/2025	500	37785.00
10b5-1 Sales for Brannin J. McBee 2022 Irrevocable Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/29/2025	25000	1890665.00
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/29/2025	102835	7777061.41
10b5-1 Sales for CANIS MAJOR 2024 IRREVOCABLE TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/29/2025	3000	226710.00
10b5-1 Sales for CANIS MAJOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/29/2025	1000	75570.00
10b5-1 Sales for CANIS MINOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/29/2025	1000	75570.00
10b5-1 Sales for CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/29/2025	25000	1890665.00
10b5-1 Sales for CANIS MINOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/29/2025	8335	630347.71
10b5-1 Sales for CANIS MAJOR SM TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/22/2025	500	42702.50
10b5-1 Sales for Brannin J. McBee 2022 Irrevocable Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/22/2025	25000	2132470.00
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/22/2025	102835	8771434.73
10b5-1 Sales for CANIS MAJOR 2024 IRREVOCABLE TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/22/2025	3000	255828.90
10b5-1 Sales for CANIS MAJOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/22/2025	1000	85420.00
10b5-1 Sales for CANIS MINOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/22/2025	1000	85427.50
10b5-1 Sales for CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/22/2025	25000	2132335.00
10b5-1 Sales for CANIS MINOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/22/2025	8335	711111.36
10b5-1 Sales for CANIS MAJOR SM TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/15/2025	500	36840.95
10b5-1 Sales for Brannin J. McBee 2022 Irrevocable Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/15/2025	25000	1839335.00
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/15/2025	102835	7565920.59
10b5-1 Sales for CANIS MAJOR 2024 IRREVOCABLE TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/15/2025	3000	221045.70
10b5-1 Sales for CANIS MAJOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/15/2025	1000	73681.90
10b5-1 Sales for CANIS MINOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/15/2025	1000	73681.90
10b5-1 Sales for CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/15/2025	25000	1839335.00
10b5-1 Sales for CANIS MINOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/15/2025	8335	613234.29
10b5-1 Sales for CANIS MAJOR SM TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/08/2025	500	41885.55
10b5-1 Sales for Brannin J. McBee 2022 Irrevocable Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/08/2025	25000	2095085.00
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/08/2025	102835	8617922.64
10b5-1 Sales for CANIS MAJOR 2024 IRREVOCABLE TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/08/2025	3000	251313.30
10b5-1 Sales for CANIS MAJOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/08/2025	1000	83771.10
10b5-1 Sales for CANIS MINOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/08/2025	1000	83771.10
10b5-1 Sales for CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/08/2025	25000	2095085.00
10b5-1 Sales for CANIS MINOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/08/2025	8335	698501.34
10b5-1 Sales for CANIS MAJOR SM TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/02/2025	500	39304.85
10b5-1 Sales for Brannin J. McBee 2022 Irrevocable Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/02/2025	25000	1965242.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/02/2025	102835	8083828.50
10b5-1 Sales for CANIS MAJOR 2024 IRREVOCABLE TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/02/2025	3000	235829.10
10b5-1 Sales for CANIS MAJOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/02/2025	1000	78609.70
10b5-1 Sales for CANIS MINOR 2025 FAMILY TRUST LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/02/2025	1000	78609.70
10b5-1 Sales for CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/02/2025	25000	1965242.50
10b5-1 Sales for CANIS MINOR 2025 GRAT 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/02/2025	8335	655211.85
Non-Affiliate Donee 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/01/2025	257733	19592527.61

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for CRWV report?

The filing reports a planned sale of 1,000 shares of common stock with an aggregate market value of 101230.00, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services under Rule 144.

How many CRWV shares are outstanding according to this Form 144?

The document states that there are 386,401,201 common shares outstanding for the issuer.

When and how were the CRWV shares in this Form 144 acquired?

The 1,000 shares covered by the notice were acquired as founders shares from the issuer on 02/25/2019, with payment made on the same date.

What recent CRWV share sales are disclosed for the past three months?

The filing lists multiple common stock sales in December 2025 and January 2026 by various trusts and entities via Rule 10b5-1 plans, plus a Non-Affiliate Donee sale of 257,733 shares on 12/01/2025 for gross proceeds of 19592527.61.

Are the recent CRWV stock sales made under Rule 10b5-1 trading plans?

Yes. Many of the disclosed sales are identified as 10b5-1 Sales for various trusts and entities, indicating they were executed under pre-arranged trading plans that comply with Rule 10b5-1.

What representation does the seller make in signing this CRWV Form 144?

By signing, the person for whose account the securities are sold represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and this also applies as of the 10b5-1 plan adoption date if such a plan is used.